• Japanese
  • Korean
  • Chinese
Cover Image

Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Open-Angle Glaucoma Global Clinical Trials Review, H1, 2015" provides an overview of Open-Angle Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Open-Angle Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Introduction 6
  • Open-Angle Glaucoma 6
  • Report Guidance 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Top Five Countries Contributing to Clinical Trials in Central and South America 14
  • Clinical Trials by G7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 19
  • Clinical Trials in E7 Countries by Trial Status 20
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 24
  • Unaccomplished Trials of Open-Angle Glaucoma 25
  • Subjects Recruited Over a Period of Time 29
  • Clinical Trials by Sponsor Type 30
  • Prominent Sponsors 31
  • Top Companies Participating in Open-Angle Glaucoma Therapeutics Clinical Trials 32
  • Prominent Drugs 33
  • Clinical Trial Profiles 34
  • Clinical Trial Overview of Top Companies 34
  • Novartis AG 34
  • Clinical Trial Overview of Novartis AG 34
  • Actavis plc 41
  • Clinical Trial Overview of Actavis plc 41
  • Pfizer Inc. 45
  • Clinical Trial Overview of Pfizer Inc. 45
  • Santen Pharmaceutical Co., Ltd. 48
  • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd. 48
  • Aerie Pharmaceuticals, Inc. 51
  • Clinical Trial Overview of Aerie Pharmaceuticals, Inc. 51
  • Merck & Co., Inc. 53
  • Clinical Trial Overview of Merck & Co., Inc. 53
  • Valeant Pharmaceuticals International, Inc. 54
  • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc. 54
  • QLT Inc. 55
  • Clinical Trial Overview of QLT Inc. 55
  • Mati Therapeutics Inc. 56
  • Clinical Trial Overview of Mati Therapeutics Inc. 56
  • Kowa Company, Ltd. 57
  • Clinical Trial Overview of Kowa Company, Ltd. 57
  • Clinical Trial Overview of Top Institutes / Government 58
  • Aristotle University Of Thessaloniki 58
  • Clinical Trial Overview of Aristotle University Of Thessaloniki 58
  • Medical University of Vienna 59
  • Clinical Trial Overview of Medical University of Vienna 59
  • Tehran University of Medical Sciences 60
  • Clinical Trial Overview of Tehran University of Medical Sciences 60
  • The University of Tokyo 61
  • Clinical Trial Overview of The University of Tokyo 61
  • University of Colorado 62
  • Clinical Trial Overview of University of Colorado 62
  • University of Colorado Denver 63
  • Clinical Trial Overview of University of Colorado Denver 63
  • Association for Research in Supporting System of Chronic Diseases 64
  • Clinical Trial Overview of Association for Research in Supporting System of Chronic Diseases 64
  • Beijing Tongren Hospital 65
  • Clinical Trial Overview of Beijing Tongren Hospital 65
  • Federal University of Sao Paulo 66
  • Clinical Trial Overview of Federal University of Sao Paulo 66
  • Kyoto Prefectural University of Medicine 67
  • Clinical Trial Overview of Kyoto Prefectural University of Medicine 67
  • Five Key Clinical Profiles 68

Appendix 95

  • Abbreviations 95
  • Definitions 95
  • Research Methodology 96
  • Secondary Research 96
  • About GlobalData 97
  • Contact Us 97
  • Disclaimer 97
  • Source 97

List of Tables

List of Tables

  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015* 7
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
  • Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
  • Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
  • Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
  • Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
  • Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
  • Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
  • Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015* 21
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
  • Open-Angle Glaucoma Therapeutics, Global, Suspended Clinical Trials, 2015* 25
  • Open-Angle Glaucoma Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26
  • Open-Angle Glaucoma Therapeutics, Global, Terminated Clinical Trials, 2015* 27
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
  • Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 34
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 41
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 45
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015* 48
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aerie Pharmaceuticals, Inc., 2015* 51
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015* 53
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015* 54
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by QLT Inc., 2015* 55
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Mati Therapeutics Inc., 2015* 56
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015* 57
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Aristotle University Of Thessaloniki, 2015* 58
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 59
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 60
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2015* 61
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2015* 62
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado Denver, 2015* 63
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Association for Research in Supporting System of Chronic Diseases, 2015* 64
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing Tongren Hospital, 2015* 65
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2015* 66
  • Open-Angle Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto Prefectural University of Medicine, 2015* 67

List of Figures

List of Figures

  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
  • Open-Angle Glaucoma Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
  • Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015* 15
  • Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
  • Open-Angle Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
  • Proportion of Open-Angle Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015* 18
  • Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
  • Open-Angle Glaucoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
  • Open-Angle Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
  • Open-Angle Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
  • Open-Angle Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
  • GlobalData Methodology 96
Show More
Pricing
  • Int'l: +1-860-674-8796
  • TollFree(US): +1-866-353-3335
  • Europe: +32-2-535-7543
  • Asia: +65-6223-2436
Back to Top